Parke Bancorp (PKBK) Stock Forecast, Price & News

Parke Bancorp's stock was trading at $20.74 at the start of the year. Since then, PKBK shares have decreased by 21.7% and is now trading at $16.23.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 18th 2023.
View our PKBK earnings forecast.

Parke Bancorp, Inc. (NASDAQ:PKBK) released its quarterly earnings results on Wednesday, July, 26th. The bank reported $0.67 EPS for the quarter. The bank earned $17.46 million during the quarter. Parke Bancorp had a trailing twelve-month return on equity of 14.99% and a net margin of 37.33%.

Parke Bancorp announced a quarterly dividend on Wednesday, September 20th. Stockholders of record on Monday, October 2nd will be paid a dividend of $0.18 per share on Monday, October 16th. This represents a $0.72 annualized dividend and a dividend yield of 4.44%. The ex-dividend date is Friday, September 29th.
Read our dividend analysis for PKBK.

Parke Bancorp (NASDAQ:PKBK) pays an annual dividend of $0.72 per share and currently has a dividend yield of 4.44%. PKBK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 21.69%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for PKBK.

Parke Bancorp shares split on Wednesday, April 18th 2018. The 11-10 split was announced on Tuesday, April 17th 2018. The newly created shares were issued to shareholders after the closing bell on Tuesday, April 17th 2018. An investor that had 100 shares of stock prior to the split would have 110 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Parke Bancorp investors own include AT&T (T), Dominion Energy (D), Lazard (LAZ), OceanFirst Financial (OCFC), Verizon Communications (VZ), Exxon Mobil (XOM), AbbVie (ABBV), Abbott Laboratories (ABT), Bristol-Myers Squibb (BMY) and Enbridge (ENB).

Parke Bancorp trades on the NASDAQ under the ticker symbol "PKBK."

Parke Bancorp's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (5.15%), Dimensional Fund Advisors LP (3.10%), Cutler Capital Management LLC (2.55%), Cutler Capital Management LLC (2.03%), Geode Capital Management LLC (1.64%) and BHZ Capital Management LP (1.55%). Insiders that own company stock include Arret F Dobson, Celestino R Pennoni, Daniel J Dalton, Edward Infantolino, Jack C Sheppard Jr, Jeffrey H Kripitz, Nicholas J Pantilione, Ralph Martin Gallo and Vito S Pantilione.
View institutional ownership trends.

Shares of PKBK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PKBK stock can currently be purchased for approximately $16.23.

Parke Bancorp (NASDAQ:PKBK) has a market capitalization of $193.95 million and generates $95.86 million in revenue each year. The bank earns $41.82 million in net income (profit) each year or $3.32 on an earnings per share basis.

The company employs 104 workers across the globe.

Parke Bancorp's mailing address is 601 DELSEA DRIVE, WASHINGTON TOWNSHIP NJ, 08080. The official website for the company is www.parkebank.com. The bank can be reached via phone at (856) 256-2500, via email at investorrelations@parkebank.com, or via fax at 856-256-2590.